InvestorsHub Logo
Followers 22
Posts 3645
Boards Moderated 0
Alias Born 07/20/2006

Re: marthambles post# 17960

Tuesday, 11/28/2017 3:56:53 PM

Tuesday, November 28, 2017 3:56:53 PM

Post# of 20689

I would love to know who is buying this stock and why.


I am for one.

For a moment, let's put aside the Glatopa 40Mg & Orencia biosimilar. Let's look at the IVIG, inflammation market. Let's also include MNTA'S analytical technology in current patent applications such as -

A.METHODS FOR TREATING DISORDERS ASSOCIATED WITH FIBROSIS AND SYSTEMIC SCLEROSIS
https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20171123&CC=WO&NR=2017201491A1&KC=A1

B.METHODS FOR THE TREATMENT OF NEUROGENERATION
https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=13&ND=3&adjacent=true&locale=en_EP&FT=D&date=20170609&CC=HK&NR=1221681A1&KC=A1

C METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF KAWASAKI DISEASE
https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=18&ND=3&adjacent=true&locale=en_EP&FT=D&date=20170223&CC=US&NR=2017052200A1&KC=A1

D. METHODS AND COMPOSITIONS FOR MODULATING HAIR GROWTH
BTW - this is their 4th update in 4 years
https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=28&ND=3&adjacent=true&locale=en_EP&FT=D&date=20160823&CC=BR&NR=112012031906A2&KC=A2

If they are successful at just one of these inventions, we're talking billions. IMHO I believe a buyout might be in the works.